Accelerated Underwriting - Be Sure Your Company Gets It Right
Have you seen the SOA's recently released "Predictive Analytics & Accelerated Underwriting Survey Report"? It is a terrific reminder of what an interesting time it is to be an underwriter, actuary or data scientist in the U.S. life and health insurance industry.
Life insurance underwriting isn’t just a job – it’s an art, a science and, at times, a puzzle. To piece together a particularly complex or challenging case, it often makes sense to seek facultative consideration from a reinsurer. Find tips and tools here to make the process easier, including a sample cover letter.
This paper seeks to understand the unique set of circumstances that led to the dramatic rise in opioid prescriptions over the last few decades, and provide a brief overview of the resultant morbidity and mortality for the insured population.
The Challenges of Determining Worth - Financial Underwriting In Emerging Markets
How much is a life worth? That is a difficult question to answer. Addressing it from a social, emotional, or spiritual perspective can provide a wide range of responses – if in fact the question is answerable at all. From a strictly fiscal perspective, however, determining a person’s long-term financial value is exactly what financial underwriting in life insurance seeks to do.
Big data applications are increasingly shaping our everyday lives, making trends more transparent and patterns more predictable. Like insurance, science, notably medicine, is equally subject to the novel possibilities and demands resulting from big data. Will risks gradually decline as trends and patterns become more predictable in healthcare and for behavior? Are the days of insurance and science as we know them numbered?
Throughout the years in our columns, I get both regular mail (yes, it still exists) and emails with a variety of questions. This month would be a good time to share some of these questions (and perhaps make this an occasional column) to address some pertinent things in the current. After all, questions some of you ask, often many of you have as well…
Our paper, “Cystatin C: A Promising Test for Insurance Screening,” was published in early 2009. At that time, most studies about this test were focused solely on its role as a novel kidney disease marker.
In the interim, several hundred new studies have greatly expand- ed our knowledge about cystatin C in a broad range of contexts. For this reason, a new comprehensive literature review is needed if we are to understand the true underwriting implications of this test.
A presentation at a recent underwriting gathering was billed as being focused on the use of predictive analytics in contexts other than risk appraisal.
Feedback from several attendees suggests it was just the opposite, centered largely on their deployment in underwriting.
So much for the verisimilitude of at least some session descriptions!
Fact is, insurers are presently being inundated with risk screening options no one would have imagined possible a decade ago. The developers of some of these tools are aggressively promoting their deployment in the underwriting process.
Bilirubin is a potent antioxidant and antiinflammatory agent. While bilirubin levels tend to be lower in cigarette smokers, the adverse effects of low/below normal bilirubin impact both smokers and nonsmokers.
High normal/elevated bilirubin has been convincingly linked to a significantly lower risk of circulatory diseases, diabetes and other prevalent medical impairments. Conversely, low normal/below normal bilirubin levels are now a well-established marker for increased risk of these diseases and their complications.
It is a widely held notion that one does not have to know the job to manage people who do the job.
This certainly makes sense for most blue collar and clerical occupations.
Does the same rationale apply to non-underwriters (defined as individuals that have never been underwriters) managing underwriting professionals?
At our study groups, this is recognized as an increasingly important question, in part because the number of individuals with no underwriting background who oversee new business departments is increasing.